| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/21/2007 | CN1305494C Blood fat regulating medicine and its preparation |
| 03/21/2007 | CN1305405C Health food with subsidiary function of lowering blood sugar and lowering blood fat and its production process |
| 03/21/2007 | CN1305404C Health caring foodstuff with antihypelipidemic and antihyperglycemic function and preparation method thereof |
| 03/21/2007 | CN1305382C Yam milk powder with blood sugar lowering function |
| 03/20/2007 | US7193108 Phenylpropionic acid derivatives |
| 03/20/2007 | US7193033 Peptide having appetite stimulating activity |
| 03/20/2007 | US7192982 Modulators of peroxisome proliferator activated receptors |
| 03/20/2007 | US7192975 Arylimidazole derivatives, preparation and therapeutic used thereof |
| 03/20/2007 | US7192973 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5) |
| 03/20/2007 | US7192971 4-Heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein |
| 03/20/2007 | US7192970 Noncyclic 1,3-dicarbonyl compounds as dual PPAR agonists with potent antihyperglycemic and antihyperlipidemic activity |
| 03/20/2007 | US7192964 4-oxoimidazolidine-2-spiropiperidine derivatives |
| 03/20/2007 | US7192963 Janus Kinase 3 inhibitors; organ transplant rejection, xeno transplation, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, Crohn's disease, Alzheimer's disease, leukemia, and autoimmune diseases |
| 03/20/2007 | US7192962 Enzyme hydrolase inhibitors such as 1-ethyl-3,7-dihydro-8-((1 R,2R)-(hydroxycyclopentyl)amino)-3-(2-hydroxyethyl)-7-((3-bromo-4 -methoxyphenyl)methyl)-1H-Purine-2,6-dione, used for physiological effects |
| 03/20/2007 | US7192961 1-Carbonyl-4-(4-quinoline-)-piperazine or 1-carbonyl-4-[4-(1H-quinolin-2-{thio}one)-piperazine derivatives; retinopathy, adult respiratory distress syndrome, asthma, osteoarthritis, glomerulonephritis, psoriasis, rheumatoid arthritis, and toxic shock syndrome treatment |
| 03/20/2007 | US7192955 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/20/2007 | US7192952 2,6-Dioxo-1,2,3,6-tetrahydropurine derivatives; dipeptidyl peptidase IV inhibitors for diabetes and obesity |
| 03/20/2007 | US7192950 Psychological disorders; eating disorders; dietetics |
| 03/20/2007 | US7192947 Peptides derivatives comprising thiazepine group for the treatment of hyperlipidemic conditions |
| 03/20/2007 | US7192946 Hyperlipemia agents; bile acid transport inhibitors |
| 03/20/2007 | US7192945 Benzothiazepine derivatives |
| 03/20/2007 | US7192944 Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| 03/20/2007 | US7192940 Ether compounds |
| 03/20/2007 | US7192929 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 03/20/2007 | US7192742 Prepared by culturing Beauveria in medium; substances thus obtained are less toxic, specifically inhibit acyl-Coenzyme A: cholesterol acyltransferase, and inhibit formation of oil droplets in macrophages |
| 03/20/2007 | US7192718 Binds to Osteoclastogenesis Inhibitory Factor (OCIF) binding molecule (OBM) |
| 03/20/2007 | US7192717 GASP1: a follistatin domain containing protein |
| 03/20/2007 | US7192715 Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
| 03/20/2007 | US7192613 Allium sativum bulb absolutes and therapeutic or cosmetic uses |
| 03/20/2007 | US7192582 Human monoclonal antibodies to FC alpha receptor (CD89) |
| 03/20/2007 | CA2278509C Production method of optically active imidazole compound, synthetic intermediate therefor and production method thereof |
| 03/16/2007 | CA2520757A1 Method and composition for treatment of diabetes mellitus and impaired glucose tolerance |
| 03/15/2007 | WO2007030721A2 Processes for the preparation of (3r,4s)-4-((4-benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((s)-3-(4-fluorophenyl)-3-hydroxypropyl)-2-azetidinone, an intermediate for the synthesis of ezetimibe |
| 03/15/2007 | WO2007030574A2 1 , 4 and 1 , 5-disubstituted indole derivatives for use as ppar active compounds |
| 03/15/2007 | WO2007030559A2 1, 3-disubstituted indole derivatives for use as ppar modulators |
| 03/15/2007 | WO2007030082A1 Use of des-aspartate-angiotensin i |
| 03/15/2007 | WO2007029847A1 Bicyclic aromatic substituted pyridone derivative |
| 03/15/2007 | WO2007029834A1 Food composition |
| 03/15/2007 | WO2007029773A1 Cholesterol absorption inhibitor |
| 03/15/2007 | WO2007029631A1 Composition for amelioration of body lipid |
| 03/15/2007 | WO2007028849A1 Pyrazolecarboxamide derivatives, method of obtaining same and use thereof as inverse antagonists/agonists of the cannabinoid cb1 and opioid mu receptor |
| 03/15/2007 | WO2007028814A1 CRYSTALLINE FORMS OF 1-CHLORO-4-(ß-D-GLUCOPYRANOS-1-YL)-2-(4-ETHYNYL-BENZYL)-BENZENE, METHODS FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS |
| 03/15/2007 | WO2007028632A2 Analogs of gastric inhibitory polypeptide as a treatment for age related decreased pancreatic beta cell function |
| 03/15/2007 | WO2007028424A1 Amide derivatives as ppar activators |
| 03/15/2007 | WO2006133164A3 Anti-trkb monoclonal antibodies and uses thereof |
| 03/15/2007 | WO2006044556A3 Dual inhibitors of lipoxygenase for treating diabetes |
| 03/15/2007 | US20070061921 Transgenic cells |
| 03/15/2007 | US20070060648 Lipids from methanotrophic bacteria for cholesterol reduction |
| 03/15/2007 | US20070060647 Gene expression regulating agent |
| 03/15/2007 | US20070060641 Therapeutic agent |
| 03/15/2007 | US20070060595 Novel fused heterocyclic compound and use thereof |
| 03/15/2007 | US20070060581 1-Sulfonylindole derivatives, their preparation and their use as 5-ht6 ligands |
| 03/15/2007 | US20070060572 e.g., 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine; mitogen-activated protein kinase inhibitor; antiinflammatory agent, autoimmune diseases |
| 03/15/2007 | US20070060568 5HT2c receptor modulators |
| 03/15/2007 | US20070060546 Novel use of mifepristone and derivatives therefor as hedgehog protein signaling pathway modulators and applications of same |
| 03/15/2007 | US20070060545 Novel compounds |
| 03/15/2007 | US20070060531 Pyrazole derivative, drug composition containing the same and production intermediate therefor |
| 03/15/2007 | US20070059831 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis |
| 03/15/2007 | US20070059797 genetic enhancers comprising the nucleotide sequences that elevates transcription of a heterologous coding sequence in a host cell |
| 03/15/2007 | US20070059723 Diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with Secs-1 polypeptides |
| 03/15/2007 | US20070059357 Adiponectin production enhancer |
| 03/15/2007 | US20070059309 Culturing a host cell transformed with a nucleic acid encoding murine anti-human IFN- alpha monoclonal antibody 9F3; culture product neutralizes all seven of recombinant human IFN- alpha subtypes tested; diseases involving cell overexpression; autoimmune diseases; antidiabetic agents; lupus (SLE) |
| 03/15/2007 | US20070059290 Transcriptional regulation of target genes |
| 03/15/2007 | DE102005017605B4 Substituierte 2-Aminoalkylthio-benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted 2-aminoalkylthio-benzimidazoles, process for their preparation and their use as medicaments |
| 03/15/2007 | CA2623412A1 Analogs of gastric inhibitory polypeptide as a treatment for age related decreased pancreatic beta cell function |
| 03/15/2007 | CA2622069A1 Treatment of diabetes related obesity |
| 03/15/2007 | CA2621474A1 1,3-disubstituted indole derivatives for use as ppar modulators |
| 03/15/2007 | CA2621470A1 Bicyclic aromatic substituted pyridone derivative |
| 03/15/2007 | CA2621406A1 Pparactive compounds |
| 03/15/2007 | CA2621314A1 Crystalline forms of 1-chloro-4-(.beta.-d-glucopyranos-1-yl)-2-(4-ethynyl-benzyl)-benzene, methods for its preparation and the use thereof for preparing medicaments |
| 03/15/2007 | CA2621275A1 1 , 4 and 1 , 5-disubstituted indole derivatives for use as ppar active compounds |
| 03/15/2007 | CA2616058A1 Processes for the preparation of (3r,4s)-4-((4-benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((s)-3-(4-fluorophenyl)-3-hydroxypropyl)-2-azetidinone, an intermediate for the synthesis of ezetimibe |
| 03/15/2007 | CA2597148A1 Amide derivatives as ppar activators |
| 03/14/2007 | EP1762574A2 Chemical modification of proteins to improve biocompatibility and bioactivity |
| 03/14/2007 | EP1762568A1 Pyrazole derivatives |
| 03/14/2007 | EP1762234A1 Ampk activator |
| 03/14/2007 | EP1761532A1 Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 03/14/2007 | EP1761522A1 Compounds and methods for treating dyslipidemia |
| 03/14/2007 | EP1761521A1 Compounds and methods for treating dyslipidemia |
| 03/14/2007 | EP1761519A1 Indole derivatives as histamine receptor antagonists |
| 03/14/2007 | EP1761517A1 Novel imidazoles and triazoles, the production thereof, and the use of the same as medicaments |
| 03/14/2007 | EP1761513A1 Tetracyclic compounds as estrogen ligands |
| 03/14/2007 | EP1761489A1 Crystalline form of atorvastatin hemi calcium |
| 03/14/2007 | EP1761482A1 Ortho-substituted (3-hydroxyphenyl)-acetic acid benzylidene hydrazides |
| 03/14/2007 | EP1761257A1 Use of acetyl l-carnitine for the preparation of a medicine for the treatment of neuropathic pain in diabetic patients |
| 03/14/2007 | EP1511728B1 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics |
| 03/14/2007 | EP1448235B1 Oral controlled release pharmaceutical compositions of 5,8,14-triazatetracyclo 10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene |
| 03/14/2007 | EP1406897B1 Compounds |
| 03/14/2007 | EP1399152B1 Pharmaceutical composition comprising a lipase inhibitor and a sucrose fatty acid mono-ester |
| 03/14/2007 | EP1397681B1 Method for identification of agents for the treatment of diabetes |
| 03/14/2007 | EP1242083B1 Phenoxypropanolamines, method for producing them and pharmaceutical compositions containing them |
| 03/14/2007 | EP1011637B1 Modulation of drug loading in multivesicular liposomes |
| 03/14/2007 | EP0998471B1 Substituted heterocyclic compounds, method for preparing and compositions containing same |
| 03/14/2007 | EP0944648B1 Glp-1 derivatives |
| 03/14/2007 | CN1930152A 1,3-dioxane derivatives and analogues thereof useful in the treatment of I.A. obesity and diabetes |
| 03/14/2007 | CN1930145A Cycloalkanopyridine derivative |
| 03/14/2007 | CN1930141A Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof |
| 03/14/2007 | CN1930126A 吡啶酮衍生物 Pyridine derivatives |
| 03/14/2007 | CN1929843A Composition for treating hyperlipoidemia |
| 03/14/2007 | CN1929832A Use of metformin and orlistat for the treatment or prevention of obesity |